Plasma Protein Therapeutic Market Report By Type (Immunoglobulins, Albumin, Coagulation Factors, Alpha-1 Proteinase Inhibitor And Others), Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210720
April 2019
Report Formats:

As per this study, the Global Plasma Protein Therapeutic Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Plasma protein therapeutic comprises of plasma-derived and recombinant analog therapies. These involve the treatment of various rare, life-threatening, chronic and genetic diseases.  Some of the diseases that can be treated by using plasma protein therapeutic include bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis and infectious diseases such as tetanus, hepatitis, and rabies. Immunoglobulins, albumin, coagulation factors, and alpha-1 proteinase inhibitor are types of plasma protein therapeutic.
 
Market Dynamics
 
The increasing applications of plasma proteins in the pharmaceutical industry are driving market growth. Additionally, growing expenditure in the healthcare industry along with the introduction of new plasma-based therapies is further fuelling market growth. On the other hand, slower approval procedure and implementation of stringent regulation policies may restrict market growth. Whereas, increasing demand for plasma-based therapies in emerging economies is expected to create potential opportunity during the forecast period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of plasma protein therapeutic.
 
Market Segmentation
 
The broad plasma protein therapeutic market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Immunoglobulins                                                
  • Albumin                                                  
  • Coagulation Factors                                                            
  • Alpha-1 proteinase inhibitor                                                           
  • Others 
 
By Application
  • Hemophilia                                                            
  • Primary Immunodeficiency Disorder                                                          
  • Idiopathic Thrombocytopenic Purpura                                                       
  • Secondary Immunodeficiency                                                       
  • Others  
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for plasma protein therapeutic in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Plasma Protein Therapeutic Market By Revenue (USD MN)
 
Europe Plasma Protein Therapeutic Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the plasma protein therapeutic market include Baxter, Biotest, Chengdu Inst., China Biologics, CSL Behring, Grifols, Kedrion, Octapharma, and Shire Plc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Plasma Protein Therapeutic
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Plasma Protein Therapeutic Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY TYPE
  • Market In Immunoglobulins                                                
  • Market In Albumin                                                  
  • Market In Coagulation Factors                                                             
  • Market In Alpha-1 proteinase inhibitor                                                           
  • Market In Others
 
5. PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY APPLICATION
  • Market In Hemophilia                                                            
  • Market In Primary Immunodeficiency Disorder                                                          
  • Market In Idiopathic Thrombocytopenic Purpura                                                        
  • Market In Secondary Immunodeficiency                                                       
  • Market In Others
 
6. PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.)Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK)Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of EuropeMarket Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE PLASMA PROTEIN THERAPEUTIC COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE PLASMA PROTEIN THERAPEUTIC INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Baxter                                                        
  • Biotest                                                         
  • Chengdu Inst. 
  • China Biologics                                                          
  • CSL Behring        
  • Grifols                                                          
  • Kedrion                                                       
  • Octapharma                                                              
  • Shire Plc.                                                      
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Plasma Protein Therapeutic
Table 2.  Global Plasma Protein Therapeutic Market By Type
Table 3.  Global Plasma Protein Therapeutic Market By Application
Table 4.  Global Plasma Protein Therapeutic Market By Geography
Table 5.  North America Plasma Protein Therapeutic Market
Table 6.  Europe Plasma Protein Therapeutic Market
Table 7.  Asia Pacific Plasma Protein Therapeutic Market
Table 8.  Latin America Plasma Protein Therapeutic Market
Table 9.  Middle East And Africa Plasma Protein Therapeutic Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Plasma Protein Therapeutic Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Plasma Protein Therapeutic
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Plasma Protein TherapeuticMarket By Type
Fig. 8.     Global Plasma Protein TherapeuticMarket By Application
Fig. 9.     Global Plasma Protein TherapeuticMarket By Geography
Fig. 10.   North America Plasma Protein TherapeuticMarket
Fig. 11.   Europe Plasma Protein TherapeuticMarket
Fig. 12.   Asia Pacific Plasma Protein TherapeuticMarket
Fig. 13.   Latin America Plasma Protein TherapeuticMarket
Fig. 14.   Middle East And Africa Plasma Protein TherapeuticMarket
Fig. 15.   Market Share Of Plasma Protein TherapeuticCompanies
Fig. 16.   Recent Developments In Plasma Protein TherapeuticIndustry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials